Carregant...
Treatment of Infants Identified by Newborn Screening for Severe Combined Immunodeficiency
BACKGROUND: Severe combined immunodeficiency (SCID) is characterized by severely impaired T cell development and is fatal without treatment. Newborn screening (NBS) for SCID permits identification of affected infants before development of opportunistic infections and other complications. Substantial...
Guardat en:
| Publicat a: | J Allergy Clin Immunol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5385855/ https://ncbi.nlm.nih.gov/pubmed/28270365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2017.01.005 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|